Ginkgo Bioworks, valued at $15B, begins trading today: Here’s how their business works

Ginkgo Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today

Ginkgo’s market debut is one of the largest in biotech history. It’s expected to raise about $1.6 billion for the…

Full text: https://techcrunch.com/2021/09/17/gingko-bioworks-valued-at-15b-begins-trading-today-heres-how-their-business-works/?guccounter=1

Author

Emma Betuel

Source

TechCrunch, 2021-09-17.

Supplier

Ginkgo BioWorks

Share